Metagenomi Therapeutics Email Format
Biotechnology ResearchCalifornia, United States51-200 Employees
Metagenomi Therapeutics is a biotechnology company based in Emeryville, California, focused on developing curative genetic medicines using a metagenomics-derived genome editing platform. The organization seeks to expand the capabilities of genome editing beyond current approaches to enable precise therapeutic edits anywhere in the human genome. It operates in the in vivo genome editing space, applying metagenomics to discover and develop novel tools for genome edits throughout the genome. Its target market includes patients in need of curative therapies and the medical community pursuing advanced genetic medicines. In early 2026, Metagenomi participated in industry events such as the TD Cowen Healthcare Conference, reflecting ongoing engagement with the biopharma ecosystem.